MetaStat Inc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTST research report →
Price Chart
About the company
MetaStat, Inc. , a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway.
- CEO
- Douglas A. Hamilton
- IPO
- 2009
- Employees
- 6
- HQ
- Boston, MA, US
Get TickerSpark's AI analysis on MTST
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $5.88K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.25
- P/B
- -0.00
- EV/EBITDA
- -0.20
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -15235.52%
- Net Margin
- -13652.46%
- ROE
- 146.45%
- ROIC
- 1012.33%
Latest fiscal year · YoY change
- Revenue
- $23.30K+0.0%
- Gross Profit
- $23.30K+0.0%
- Op Income
- $-3,549,875
- Net Income
- $-3,181,024-8.1%
- EPS
- $-0.59+40.4%
- OCF Growth
- -18.5%
- FCF Growth
- -19.2%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -1.14
- RSI (14)
- 100
- Avg Volume
- 12.96K
No earnings-call transcripts are available for MTST yet.
- Free Float
- 98.4%
- Shares Outstanding
- 5.88M
- Float Shares
- 5.79M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 12, 18 | Schneiderman Daniel H | other | 76,962 |
| Oct 11, 17 | Billings Paul | other | 50,000 |
| Oct 11, 17 | ZELDIS JEROME B | other | 50,000 |
| May 24, 17 | Billings Paul | other | 0 |
| Apr 4, 17 | Schneiderman Daniel H | other | 25,000 |
| Apr 4, 17 | ZELDIS JEROME B | buy | 20,000 |
| Apr 4, 17 | Driscoll Martin J | buy | 20,000 |
| Apr 4, 17 | Bronsther Oscar | buy | 20,000 |
| Apr 4, 17 | BERMAN RICHARD J | buy | 20,000 |
| Oct 30, 16 | Driscoll Martin J | buy | 28,342 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our MTST coverage
Recent articles, reports, and earnings notes.
No research on MTST yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MTST report →Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.